Evidence map›Paper›PMID 21923823›Full record

ArticleVeterinary ophthalmology2011

The effect of dorzolamide 2% on circadian intraocular pressure in cats with primary congenital glaucoma.

Kelly J Sigle, Gabriel Camaño-Garcia, Alicia L Carriquiry, Daniel M Betts, Markus H Kuehn, Gillian J McLellan

Abstract read
In one paragraph

Article in Veterinary ophthalmology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Feline glaucoma--a comprehensive review.Veterinary ophthalmology · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kelly J SigleDepartment of Veterinary Clinical Sciences, Iowa State University, Ames, IA 50011, USA.
Gabriel Camaño-Garcia
Alicia L Carriquiry
Daniel M Betts
Markus H Kuehn
Gillian J McLellan
Iowa State University · USUniversity of Iowa · USUniversity of Wisconsin–Madison · US

Funding

Structural and Functional Characterization of a Novel Model for Glaucoma ResearchK08EY018609 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI MCLELLAN, GILLIAN JANE · 2008 to 2012
$860k
NEI NIH HHS K08 EY018609NEI NIH HHS K08EY018609
6 · The paper itself

Abstract

objectiveTo determine the extent of fluctuation in circadian intraocular pressure (IOP) and the efficacy of topical dorzolamide 2% q 8 h in lowering IOP and blunting circadian fluctuation in IOP in glaucomatous cats. ANIMALS STUDIED: Seven adult cats with primary congenital glaucoma (PCG). PROCEDURES: Measurements of IOP and pupil diameter were obtained for both eyes (OU) of each cat q 4 h for 12 days. Cats were housed in a laboratory animal facility with a 12-h light:dark cycle. Baseline values were established for 2 days. For the next 5 days, placebo (1.4% polyvinyl alcohol) was administered OU q 8 h. Dorzolamide 2% was then administered OU q 8 h for a further 5 days. A multivariate mixed linear model was fitted to the data, with parameters estimated from a Bayesian perspective. The 4 am time point was selected as the reference for the purposes of comparisons.

resultsEstimated mean IOP for the reference time point pre-treatment was symmetric (about 33 mmHg OU). In all cats, IOP was significantly lower during the diurnal phase, relative to the 4 am measurements, with highest IOP observed 2-6 h after the onset of the dark phase. Circadian fluctuations in IOP were dampened during the treatment period. There was a significant decrease in IOP in all cats during the dorzolamide treatment period (estimated mean for the treatment period reference = 17.9 mmHg OU).

conclusionsTopical dorzolamide 2% q 8 h is effective in reducing IOP and IOP fluctuation in cats with PCG.

Indexed as

Administration, OphthalmicAnimalsCarbonic Anhydrase InhibitorsCat DiseasesCatsCircadian RhythmFemaleGlaucomaIntraocular PressureMaleSulfonamidesThiophenesCarbonic Anhydrase InhibitorsdorzolamideSulfonamidesThiophenes

Identifiers

PMID21923823
PMCPMC3348180
OpenAlexW1831915882

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.